PharmaCan Capital Corp Stock Toronto S.E.
Equities
MJN
CA7171151094
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
|
Jun. 27 | Cronos Group Inc. Brand Spinach®? Celebrates Summer with New Launches | CI |
Jun. 21 | Cronos Group Inc. Elects Murray Garnick as Director | CI |
Sales 2024 * | 141M 104M | Sales 2025 * | 173M 127M | Capitalization | 1.17B 858M |
---|---|---|---|---|---|
Net income 2024 * | -26M -19.06M | Net income 2025 * | 2M 1.47M | EV / Sales 2024 * | 0.83 x |
Net cash position 2024 * | 1.05B 772M | Net cash position 2025 * | 938M 687M | EV / Sales 2025 * | 1.34 x |
P/E ratio 2024 * |
-53.8
x | P/E ratio 2025 * |
-148
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.4% |
Latest transcript on PharmaCan Capital Corp
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 15-11-05 | |
James Holm
DFI | Director of Finance/CFO | 41 | 22-11-13 |
Arye Weigensberg
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
James Rudyk
BRD | Director/Board Member | 57 | 18-01-31 |
Jason Adler
BRD | Director/Board Member | 52 | 16-07-11 |
Chief Executive Officer | 37 | 15-11-05 |
1st Jan change | Capi. | |
---|---|---|
+27.19% | 5.36B | |
-33.59% | 3.4B | |
-2.97% | 2.9B | |
-24.21% | 2.53B | |
-10.11% | 2.27B | |
+43.66% | 1.84B | |
+46.15% | 1.42B | |
+41.90% | 1.38B | |
-13.92% | 1.37B |
- Stock Market
- Equities
- CRON Stock
- MJN Stock